Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NKTR
#1941
Nektar Therapeutics
73.250
0
USD
+4.11%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+4.11%
Mudança mensal
-0.03%
Mudança em 6 meses
-0.03%
Mudança anual
-0.03%
Fechamento anterior
70.360
0
Open
73.250
0
Bid
73.250
0
Ask
73.253
0
Low
73.250
0
High
73.250
0
Volume
66
Mercados
Ações
Cuidados de saúde
NKTR
Open full chart
Financials
Overview
Relatórios
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
12.15 M
12.42 M
12.62 M
12.24 M
12.41 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.29
0.47
0.52
0.69
0.39
0.49
Return on equity %
0.41
0.77
1
2.11
1.96
5.72
Return on invested capital %
254.72
426.37
531.3
747.1
563.62
829.6
Gross margin %
87.26
75.57
76.5
62.53
68.82
372.66
Operating margin %
278
437.76
408.63
292.59
106.88
969.43
EBITDA margin %
17.71
-46.1
-160.53
-202.78
-17.91
-1 441.57
Net margin %
290.65
514.03
399.98
306.31
120.86
1 135.04
Liquidity ratios
Quick ratio
9.7
9.15
7.72
6.14
4.26
—
Current ratio
9.83
9.34
8
6.45
4.26
14.35
Inventory turnover
1.39
1.6
1.24
1.91
3.81
—
Asset turnover
0.09
0.08
0.1
0.16
0.28
0.23
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
26.31
33.77
24.37
15.21
12.82
12.68
EBIT per share
1.22
-4.91
-12.82
-14.98
-1.58
-12.37
EBITDA per share
2.27
-3.84
-11.84
-14.43
-1.29
-12.03
Total debt per share
—
—
—
—
—
—
Cash per share
89.19
60.06
40.48
23.97
18.62
60.91
Net current asset value per share
95.59
65.11
43.76
26.11
19.06
63.5
Tangible book value per share
84.06
49.35
23.26
10.34
4.43
11.62
Working capital per share
85.86
58.13
38.3
22.06
14.58
45.41
Book value per share
90.49
55.61
29.39
10.34
4.43
11.62
Notícias
Oppenheimer eleva preço-alvo da Nektar Therapeutics para US$ 140
Oppenheimer raises Nektar Therapeutics price target to $140
Ações da Nektar Therapeutics atingem máxima de 52 semanas a US$ 76,30
Nektar Therapeutics stock hits 52-week high at 76.3 USD
Nektar Therapeutics encerra 2025 com reforço de caixa e expansão em P&D
Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
Nektar Therapeutics stock hits 52-week high at 75.19 USD
Nektar Therapeutics conclui oferta pública de US$ 460 milhões